Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Forrester

Pfizer calls on pharmacists to promote medicine adherence

Unused medicines cost NHS England £300m per year

- PMLiVE

Pfizer’s RA drug tofacitinib tops methotrexate in phase III

Trial results back drug as major new treatment in rheumatoid arthritis

- PMLiVE

Boehringer-Lilly tap into behavioural change for online diabetes programme

Part of the partners' Tradjenta marketing, My Well Planner offers personalised educational resources

- PMLiVE

Boehringer launches Facebook game

Syrum aims to teach players about the complexity of medicine development

- PMLiVE

Interview: Cavan Redmond, WebMD

The new CEO of WebMD talks to PMLiVE about his move from Pfizer

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

- PMLiVE

The Research Partnership makes senior US appointments

Paul Dick joins from IMS Health and Phil Rosenberg arrives from BioVid

Grey Healthcare Group introduces brand influence tracker

Programme helps assess the impact of healthcare companies online

- PMLiVE

AstraZeneca drops Palatin’s obesity drug after trial subject suffers allergic reaction

But collaboration with the US biotech remains in place

- PMLiVE

Pfizer’s Andrew Thomas takes up UK comms agency role

Joins London-based Red Door Communications as head of international

Pfizer gets US approval for leukaemia drug Bosulif

FDA grants the tyrosine kinase inhibitor a licence to treat chronic myelogenous leukaemia

- PMLiVE

Pfizer’s Inlyta gets EU approval for advanced kidney cancer

Available as second-line therapy after treatment with pharma firm's own Sutent

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links